Verified Nov 2026
Other
·
Leobendorf, Lower Austria
·
Since 1976
Croma Pharma is a family-owned pharmaceutical manufacturer based in Leobendorf, Austria, founded in 1976, with 500–1,000 employees and estimated revenue of $100–250 million. The company specializes in minimally invasive aesthetic medicine, producing hyaluronic acid fillers, botulinum toxin injectables, and related medical devices. It distributes products across 70–80 markets globally and operates contract manufacturing for orthopedics and ophthalmology.
Croma Pharma at a glance
Revenue
$100-250M
Est. band
Employees
500-1,000
Founded
1976
Headquarters
Leobendorf, Lower Austria
Industries
Automotive
Electric Vehicles
Medical
Renewable Energy
Industrial Equipment
Overview
Croma Pharma is a family-owned pharmaceutical manufacturer based in Leobendorf, Austria, founded in 1976, with 500–1,000 employees and estimated revenue of $100–250 million. The company specializes in minimally invasive aesthetic medicine, producing hyaluronic acid fillers, botulinum toxin injectables, and related medical devices. It distributes products across 70–80 markets globally and operates contract manufacturing for orthopedics and ophthalmology.
At a glance
Attribute | Detail |
|---|---|
Founded | 1976 |
Headquarters | Leobendorf, Lower Austria |
Employees | 500-1,000 |
Revenue | $100-250M (estimated) |
What Croma Pharma makes
Croma manufactures injectables including hyaluronic acid fillers, botulinum toxin products, PDO threads, biostimulators, and skincare formulations, and holds FDA approval for products such as Obagi saypha ChIQ as of July 2026.
Products and capabilities described on the company's own site include LED (source: cromapharma.com).
Latest developments
2026-10-05 — Croma-Pharma Expands Its Portfolio in Canada With saypha® lips Lidocaine and Exprecell™ (businesswire.com)
2026-07-01 — Croma-Pharma Announces FDA Approval of Obagi saypha® ChIQ™ in the United States (businesswire.com)
2026-05-27 — Medfile i Croma łączą siły dla rynku medycyny estetycznej | program do gabinetu (medfile.pl)
2026-04-23 — Croma Pharma Launches AI-Driven Tech Venture to Revolutionize Aesthetic Medicine via Clinicore Platform (businesswire.com)
2026-04-08 — Croma-Pharma Acquires Synocrom™ and Returns to Orthopaedics (businesswire.com)
2026-01-09 — Croma Pharma expands skincare line - Aesthetics Journal (aestheticsjournal.com)
Facilities
Croma Pharma is headquartered in Leobendorf, Lower Austria. Public sources also reference these locations:
Austria — cromapharma.com
Company details
The company distributes its aesthetic medicine portfolio to healthcare professionals and clinics across North America, Europe, Asia-Pacific, and other regions, maintaining a "Made in Austria" standard. Croma Pharma was founded in 1976, has an estimated 500-1,000 employees, and is headquartered in Leobendorf, Lower Austria.
Frequently asked questions
What does Croma Pharma do?
Croma Pharma is a family-owned pharmaceutical manufacturer based in Leobendorf, Austria, founded in 1976, with 500–1,000 employees and estimated revenue of $100–250 million. The company specializes in minimally invasive aesthetic medicine, producing hyaluronic acid fillers, botulinum toxin injectables, and related medical devices. It distributes products across 70–80 markets globally and operates contract manufacturing for orthopedics and ophthalmology.
Where is Croma Pharma headquartered?
Croma Pharma is headquartered in Leobendorf, Lower Austria (6 Industriezeile, Leobendorf, Lower Austria, 2100).
When was Croma Pharma founded?
Croma Pharma was founded in 1976.
How big is Croma Pharma?
Croma Pharma has an estimated 500-1,000 employees, with revenue in the $100-250M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
